Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847–875. https://doi.org/10.1016/S2213-8587(21)00235-7

Article  PubMed  PubMed Central  Google Scholar 

Loriaux DL (2017) Diagnosis and differential diagnosis of Cushing’s syndrome. N Engl J Med 376:1451–1459. https://doi.org/10.1056/NEJMra1505550

Article  CAS  PubMed  Google Scholar 

Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM et al (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526–1540. https://doi.org/10.1210/jc.2008-0125

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reincke M, Fleseriu M (2023) Cushing syndrome: a review. JAMA 330(2):170–181. https://doi.org/10.1001/jama.2023.11305

Article  CAS  PubMed  Google Scholar 

Findling JW, Raff H (2017) DIAGNOSIS OF ENDOCRINE DISEASE: differentiation of pathologic/neoplastic hypercortisolism (Cushing’s syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing’s syndrome). Eur J Endocrinol 176(5):R205–R216. https://doi.org/10.1530/eje-16-0946

Article  CAS  PubMed  Google Scholar 

Vassiliadi DA, Tsagarakis S (2018) DIAGNOSIS OF ENDOCRINE DISEASE: the role of the desmopressin test in the diagnosis and follow-up of Cushing’s syndrome. Eur J Endocrinol 178(5):R201–R214. https://doi.org/10.1530/eje-18-0007

Article  CAS  PubMed  Google Scholar 

Scaroni C, Mondin A, Ceccato F (2022) How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing). Pituitary 25(5):701–704. https://doi.org/10.1007/s11102-022-01222-2

Article  PubMed  PubMed Central  Google Scholar 

Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40(4):479–484. https://doi.org/10.1111/j.1365-2265.1994.tb02486.x

Article  CAS  PubMed  Google Scholar 

Limumpornpetch P, Morgan AW, Tiganescu A, Baxter PD, Nyawira Nyaga V, Pujades-Rodriguez M et al (2022) The effect of endogenous cushing syndrome on all-cause and cause-specific mortality. J Clin Endocrinol Metab 107(8):2377–2388. https://doi.org/10.1210/clinem/dgac265

Article  PubMed  PubMed Central  Google Scholar 

van Haalen FM, Broersen LHA, Jorgensen JO, Pereira AM, Dekkers OM (2015) MANAGEMENT OF ENDOCRINE DISEASE: mortality remains increased in Cushing’s disease despite biochemical remission: a systematic review and meta-analysis. Eur J Endocrinol 172(4):R143–R149. https://doi.org/10.1530/eje-14-0556

Article  PubMed  Google Scholar 

Yanovski JA (1993) Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. JAMA 269(17):2232. https://doi.org/10.1001/jama.1993.03500170062035

Article  CAS  PubMed  Google Scholar 

Valassi E, Swearingen B, Lee H, Nachtigall LB, Donoho DA, Klibanski A et al (2009) Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing’s syndrome. J Clin Endocrinol Metab 94(12):4851–4859. https://doi.org/10.1210/jc.2009-1500

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gatta B, Chabre O, Cortet C, Martinie M, Corcuff J-Bt, Roger P et al (2007) Reevaluation of the Combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild Cushing’s disease from pseudo-Cushing’s syndrome. J Clin Endocrinol Metab. 92(11):4290–3. https://doi.org/10.1210/jc.2006-2829

Article  CAS  PubMed  Google Scholar 

Pecori Giraldi F, Pivonello R, Ambrogio AG, De Martino MC, De Martin M, Scacchi M et al (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clinical Endocrinology. 66(2):251–257. https://doi.org/10.1111/j.1365-2265.2006.02717.x

Article  CAS  PubMed  Google Scholar 

Malerbi DA, Fragoso MC, Vieira Filho AH, Brenlha EM, Mendonca BB (1996) Cortisol and adrenocorticotropin response to desmopressin in women with Cushing’s disease compared with depressive illness. J Clin Endocrinol Metab 81(6):2233–2237. https://doi.org/10.1210/jcem.81.6.8964857

Article  CAS  PubMed  Google Scholar 

Tirabassi G, Papa R, Faloia E, Boscaro M, Arnaldi G (2011) Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing’s disease and pseudo-Cushing state: a comparative study. Clin Endocrinol (Oxf) 75(5):666–672. https://doi.org/10.1111/j.1365-2265.2011.04096.x

Article  CAS  PubMed  Google Scholar 

Rollin GAF, Costenaro F, Gerchman F, Rodrigues TC, Czepielewski MA (2015) Evaluation of the DDAVP test in the diagnosis of Cushing’s Disease. Clin Endocrinol 82(6):793–800. https://doi.org/10.1111/cen.12661

Article  CAS  Google Scholar 

Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK (1998) A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 83(4):1163–1167. https://doi.org/10.1210/jcem.83.4.4733

Article  CAS  PubMed  Google Scholar 

Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M (2005) Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing’s syndrome. Eur J Endocrinol 153(6):803–809. https://doi.org/10.1530/eje.1.02042

Article  CAS  PubMed  Google Scholar 

Cunningham JM, Buxton OM, Weiss RE (2002) Circadian variation in Cushing’s disease and pseudo-Cushing states by analysis of F and ACTH pulsatility. J Endocrinol Invest 25(9):791–799. https://doi.org/10.1007/BF03345514

Article  CAS  PubMed  Google Scholar 

Viardot A, Huber P, Puder JJ, Zulewski H, Keller U, Muller B (2005) Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J Clin Endocrinol Metab 90(10):5730–5736. https://doi.org/10.1210/jc.2004-2264

Article  CAS  PubMed  Google Scholar 

Ozkaya HM, Keskin FE, Tuten A, Korkmaz E, Oktay HZ, Kadioglu P (2017) Late-night salivary cortisol is unaltered in patients with polycystic ovarian syndrome (Pcos), irrespective of disease phenotype, and in obese women, irrespective of the presence of Pcos. Endocr Pract 23(9):1045–1052. https://doi.org/10.4158/EP171887.OR

Article  PubMed  Google Scholar 

Alwani RA, Schmit Jongbloed LW, de Jong FH, van der Lely AJ, de Herder WW, Feelders RA (2014) Differentiating between Cushing’s disease and pseudo-Cushing’s syndrome: comparison of four tests. Eur J Endocrinol 170(4):477–486. https://doi.org/10.1530/eje-13-0702

Article  CAS  PubMed  Google Scholar 

Aberle J, Schulze Zur Wiesch C, Flitsch J, Veigel J, Schon G, Jung R et al (2018) Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing’s disease in an obese population. J Endocrinol Invest. 41(11):1325–31. https://doi.org/10.1007/s40618-018-0870-8

Article  CAS  PubMed  Google Scholar 

Hinojosa-Amaya JM, González-Colmenero FD, Alvarez-Villalobos NA, Salcido-Montenegro A, Quintanilla-Sánchez C, Moreno-Peña PJ, et al. Supplementary Material: The conundrum of differentiating Cushing’s syndrome from non‑neoplastic hypercortisolism: a systematic review and meta‑analysis, Repositorio Académico Digital: Universidad Autónoma de Nuevo León.; 2023. Deposited 22 September 2023. http://eprints.uanl.mx/id/eprint/26213.

Shim SR, Kim SJ, Lee J (2019) Diagnostic test accuracy: application and practice using R software. Epidemiol Health 41:e2019007. https://doi.org/10.4178/epih.e2019007

Article  PubMed  PubMed Central  Google Scholar 

Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M et al (2006) Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 91(7):2582–2586. https://doi.org/10.1210/jc.2005-2143

Article  CAS  PubMed  Google Scholar